Skip to content

A comparative clinical trial to study the effect of Herbal Supplements- NRCC-01 & NRCC-02 in pre-diabetic subjects.

A randomized double blind placebo controlled trial of Herbal Supplements (NRCC-01 and NRCC-02) in the management of Pre-diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/05/001729
Enrollment
150
Registered
2011-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pre-diabetes

Interventions

Intervention1: Group I:NRCC01 DS grade: 2 capsules(each 250mg) BID orally, for 6 weeks Intervention2: Group II: NRCC01 DS grade: 2 capsules(each 125mg) BID orally,for 6 weeks Intervention3: Group III:

Sponsors

Natural Remedies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ?Understanding of the study procedures and agreement to participate in the study by giving written informed consent ?Impaired glucose tolerance/ impaired fasting glucose or both ?Preferable BMI≥ 25 to ≤ 30

Exclusion criteria

Exclusion criteria: ?Patients diagnosed with type 2 diabetes or taking glucose-lowering agents or insulin ?Pregnant or lactating females ?Drug and alcohol abuse. ?Mental illness or dementia. ?Participation in other clinical trials ? Advanced chronic illness that would impair follow-up or monitoring.

Design outcomes

Primary

MeasureTime frame
To compare the effect of NRCC-01 or NRCC-02 administration on FPG & OGTTTimepoint: day 0, day 14, day 28 and day 42

Secondary

MeasureTime frame
To compare the effect of NRCC-01 or NRCC-02 administration on Lipid profile Body weight & BMITimepoint: 6 weeks

Countries

India

Contacts

Public ContactDr K R Raveendra

Karnataka university

drkrraveendra@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026